Literature DB >> 15499201

Novel nonsynonymous single nucleotide polymorphisms in the CYP2D6 gene.

Akiko Soyama1, Takashi Kubo, Atsuko Miyajima, Yoshiro Saito, Kisho Shiseki, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Hitonobu Tomoike, Shogo Ozawa, Jun-ichi Sawada.   

Abstract

Cytochrome P450 (CYP) 2D6 is an important drug-metabolizing enzyme, and its gene is known to be highly polymorphic. Here, we report five novel nonsynonymous single nucleotide polymorphisms (SNPs), and 65 other sequence variations detected from the gene coding for cytochrome P450 (CYP) 2D6 in 254 Japanese subjects. Two of the novel nonsynonymous SNPs were associated with the *10 key SNP, C100T. Among the 65 variations, 23 were novel, including 12 SNPs in 5'-flanking, 1 in 5'-untranslated, and 10 in intronic regions. The nonsynonymous SNPs in the CYP2D6 gene were as follows: 73 C>T (Arg25Trp, exon 1), 972 C>T (Ala90Val, exon 2), 1611 T>A (Phe120Ile, exon 3), 1720 A>C (Glu156Ala, exon 3), 3172 A>C (Glu334Ala, exon 7). The SNPs, 73C>T, 972 C>T, 1611 T>A, 1720 A>C and 3172 A>C were linked with *10, *1, *10, *1 and *2, respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15499201     DOI: 10.2133/dmpk.19.313

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  6 in total

1.  Limited effects of frequent CYP2D6*36-*10 tandem duplication allele on in vivo dextromethorphan metabolism in a Japanese population.

Authors:  Kazuma Kiyotani; Makiko Shimizu; Toshio Kumai; Tetsuya Kamataki; Shinichi Kobayashi; Hiroshi Yamazaki
Journal:  Eur J Clin Pharmacol       Date:  2010-08-11       Impact factor: 2.953

2.  Determination of novel CYP2D6 haplotype using the targeted sequencing followed by the long-read sequencing and the functional characterization in the Japanese population.

Authors:  Koya Fukunaga; Eiji Hishinuma; Masahiro Hiratsuka; Ken Kato; Takuji Okusaka; Takeo Saito; Masashi Ikeda; Teruhiko Yoshida; Hitoshi Zembutsu; Nakao Iwata; Taisei Mushiroda
Journal:  J Hum Genet       Date:  2020-08-05       Impact factor: 3.172

Review 3.  Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

Authors:  Shu-Feng Zhou
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 4.  Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.

Authors:  Victoria M Pratt; Larisa H Cavallari; Andria L Del Tredici; Andrea Gaedigk; Houda Hachad; Yuan Ji; Lisa V Kalman; Reynold C Ly; Ann M Moyer; Stuart A Scott; R H N van Schaik; Michelle Whirl-Carrillo; Karen E Weck
Journal:  J Mol Diagn       Date:  2021-06-10       Impact factor: 5.341

5.  Systematic functional study of cytochrome P450 2D6 promoter polymorphisms in the Chinese Han population.

Authors:  Xueli Gong; Yichen Liu; Xiaoqing Zhang; Zhiyun Wei; Ran Huo; Lu Shen; Lin He; Shengying Qin
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

6.  Results and challenges of Cytochrome P450 2D6 (CYP2D6) testing in an ethnically diverse South Florida population.

Authors:  Daria Salyakina; Sharmeen Roy; Weize Wang; Mailin Oliva; Rohan Akhouri; Ileana Sotto; Nicole Mulas; Rafaela Solano; José R Fernández; Stephanie Sanchez; Uzma Shamshad; Chad Perlyn; Jennifer McCafferty-Fernandez
Journal:  Mol Genet Genomic Med       Date:  2019-08-07       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.